Seven pharma executives are expected to face tough questions about the price of their drugs Tuesday before the U.S. Senate Finance Committee. They’ll also be answering to a group that’s received hundreds of thousands of dollars in campaign contributions from their own companies’ PACs.
These Senators Received The Biggest Checks From Pharma Companies Testifying Tuesday
